← Back to Analyst Consensus 
MRVI Buy
MARAVAI LIFESCIENCES HOLDINGS, INC.
Current Price —
Implied Upside —
Analysts 14
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Next Earnings
Nov 4, 2026 (9 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Sep 9, 2026 | UBS | maintain | Neutral → Neutral | — | 54% |
| Aug 7, 2026 | Wells Fargo | maintain | Overweight → Overweight | — | 54% |
| May 8, 2026 | Wells Fargo | maintain | Overweight → Overweight | — | 54% |
| Dec 15, 2025 | Wells Fargo | maintain | Overweight → Overweight | $4.5 | 54% |
| Aug 12, 2025 | RBC Capital | maintain | Outperform → Outperform | $5 | 55% |
| Aug 12, 2025 | Craig-Hallum | maintain | Buy → Buy | $5 | 54% |
| May 13, 2025 | Craig-Hallum | maintain | Buy → Buy | $10 | 54% |
| May 13, 2025 | Baird | maintain | Neutral → Neutral | $2 | 55% |
| Mar 25, 2025 | Morgan Stanley | maintain | Equal-Weight → Equal-Weight | $5 | 54% |
| Mar 21, 2025 | UBS | maintain | Neutral → Neutral | $2.5 | 54% |
| Mar 3, 2025 | B of A Securities | maintain | Buy → Buy | $8 | 53% |
| Feb 26, 2025 | Baird | downgrade | Outperform → Neutral | $3 | 55% |
| Dec 5, 2024 | Goldman Sachs | downgrade | Neutral → Sell | $4.25 | 54% |
| Nov 14, 2024 | Wolfe Research | initiate | — → Peer Perform | $0 | 53% |
| Nov 8, 2024 | RBC Capital | maintain | Outperform → Outperform | $13 | 55% |
| Nov 8, 2024 | William Blair | downgrade | Outperform → Market Perform | $0 | 48% |
| Nov 8, 2024 | Baird | maintain | Outperform → Outperform | $9 | 55% |
| Oct 8, 2024 | Goldman Sachs | maintain | Neutral → Neutral | $7 | 54% |
| Aug 27, 2024 | Wells Fargo | initiate | — → Overweight | $10 | 54% |
| Aug 16, 2024 | RBC Capital | reiterate | Outperform → Outperform | $15 | 55% |
| Aug 13, 2024 | Morgan Stanley | downgrade | Overweight → Equal-Weight | $10 | 54% |
| Aug 8, 2024 | Goldman Sachs | maintain | Neutral → Neutral | $8 | 54% |
| Aug 8, 2024 | UBS | maintain | Neutral → Neutral | $11 | 54% |
| Jul 9, 2024 | Goldman Sachs | maintain | Neutral → Neutral | $7 | 54% |
| May 9, 2024 | Baird | maintain | Outperform → Outperform | $10 | 55% |
| Apr 10, 2024 | Craig-Hallum | initiate | — → Buy | $15 | 54% |
| Feb 23, 2024 | RBC Capital | maintain | Outperform → Outperform | $14 | 55% |
| Feb 23, 2024 | Stifel | maintain | Buy → Buy | $10 | 53% |
| Dec 12, 2023 | B of A Securities | upgrade | Neutral → Buy | $8 | 53% |
| Nov 9, 2023 | Goldman Sachs | maintain | Neutral → Neutral | $7 | 54% |
| Nov 9, 2023 | Morgan Stanley | maintain | Overweight → Overweight | $11 | 54% |
| Aug 9, 2023 | Morgan Stanley | maintain | Overweight → Overweight | $12 | 54% |
| Aug 8, 2023 | Deutsche Bank | maintain | Buy → Buy | $17 | 57% |
| Aug 8, 2023 | RBC Capital | maintain | Outperform → Outperform | $18 | 55% |
| Aug 8, 2023 | Goldman Sachs | maintain | Neutral → Neutral | $8 | 54% |
| Aug 8, 2023 | Baird | maintain | Outperform → Outperform | $11 | 55% |
| Aug 8, 2023 | Credit Suisse | maintain | Neutral → Neutral | $11 | — |
| Aug 8, 2023 | Keybanc | downgrade | Overweight → Sector Weight | $0 | 52% |
| May 23, 2023 | Credit Suisse | downgrade | Outperform → Neutral | $14 | — |
| May 10, 2023 | Goldman Sachs | maintain | — → Neutral | $13 | 54% |
| May 10, 2023 | Morgan Stanley | maintain | — → Overweight | $27 | 54% |
| May 9, 2023 | RBC Capital | maintain | — → Outperform | $20 | 55% |
| May 9, 2023 | Goldman Sachs | downgrade | Buy → Neutral | $13 | 54% |
| May 9, 2023 | Deutsche Bank | maintain | — → Buy | $23 | 57% |
| May 9, 2023 | Credit Suisse | maintain | — → Outperform | $18 | — |
| Feb 24, 2023 | Morgan Stanley | maintain | — → Overweight | $29 | 54% |
| Feb 23, 2023 | Baird | maintain | — → Outperform | $22 | 55% |
| Feb 23, 2023 | Credit Suisse | maintain | — → Outperform | $23 | — |
| Feb 23, 2023 | Keybanc | maintain | — → Overweight | $24 | 52% |
| Jan 17, 2023 | Goldman Sachs | maintain | — → Buy | $16 | 54% |
Price Target Trend
Apr 30, 2026 Oct 26, 2026
EPS Estimates
0y —
+1y —
0q —
+1q —
Cross-Platform Signals
No cross-platform signals in the last 90 days